Jakarta Aktual – 20 June 2026 | In a significant development, the Ahold Delhaize DOJ settlement has come to fruition, with the grocery giant agreeing to pay $40 million to settle claims it reported inflated prescription prices to federal healthcare programs. This Ahold Delhaize DOJ settlement stems from allegations that the company’s pharmacies reported higher, pre-discount prices when billing Medicare Part D, Medicaid, and TRICARE, prompting the government to pay inflated reimbursements. The Ahold Delhaize DOJ settlement marks a crucial step in addressing the issue of pharmacy pricing transparency and ensuring that federal healthcare programs receive accurate information.
Ahold Delhaize USA Inc., the Quincy, Mass.-based operator of Stop & Shop, Giant, Hannaford, and Food Lion, manages grocery stores with in-store pharmacies that offer prescription savings programs to members. However, instead of reporting the discounted prices as “usual and customary” prices on claims submitted to federal healthcare programs, Ahold Delhaize’s pharmacies reported the higher, pre-discount prices. This led to the government paying more than it should on those claims, highlighting the need for the Ahold Delhaize DOJ settlement.
The Ahold Delhaize DOJ settlement will see the company pay $40 million, with about $32.9 million going toward the federal government and the rest being paid to states participating in the case. Lawrence LaBenne, a former pharmacist at an Ahold Delhaize supermarket in Pennsylvania and the whistleblower in the case, will receive more than $6 million as part of the federal share of the settlement. The Ahold Delhaize DOJ settlement serves as a reminder of the importance of transparency in pharmacy pricing and the need for companies to report accurate information to federal healthcare programs.
In other news, Ahold Delhaize has nominated Claire Peters, a former Amazon executive, as the new CEO of its US operations, effective September 8. Peters brings a wealth of international grocery and retail knowledge, having directed Amazon’s global grocery portfolio across six countries and integrated online and physical formats to improve Prime engagement. Her appointment is seen as a strategic move to drive growth and expansion in the US market, and her experience will be invaluable in navigating the complexities of the Ahold Delhaize DOJ settlement.
The Ahold Delhaize DOJ settlement and the appointment of Claire Peters as the new CEO of US operations mark significant developments for the company. As Ahold Delhaize moves forward, it will be essential to prioritize transparency and accuracy in pharmacy pricing, as well as leverage Peters’ expertise to drive growth and expansion in the US market. The Ahold Delhaize DOJ settlement serves as a crucial step in this process, and the company’s commitment to transparency and compliance will be closely watched in the coming months.
In conclusion, the Ahold Delhaize DOJ settlement highlights the importance of transparency in pharmacy pricing and the need for companies to report accurate information to federal healthcare programs. As the company moves forward, it will be essential to prioritize compliance and leverage the expertise of its new CEO to drive growth and expansion in the US market. The Ahold Delhaize DOJ settlement marks a significant development in the company’s history, and its impact will be felt in the months and years to come.
